Karuna Kui Foundation Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 343042.16%
- Profit Growth 303402.06%
- Ebitda 184044.12%
- Net Worth 12960.20%
- Total Assets 12698.22%
About Karuna Kui Foundation
Karuna Kui Foundation (KKF) is a Private Not For Profit Company incorporated in India on 11 March 2019 (Five years and 11 months 5 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Falguni Shah and Samir Shah serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85100MH2019NPL322372
-
Company No.
322372
-
Company Classification
Private Not For Profit Company
-
Incorporation Date
11 Mar 2019
-
Date of AGM
27 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Karuna Kui Foundation?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samir Shah
|
Director | 11-Mar-2019 | Current |
|
Falguni Shah
|
Director | 11-Mar-2019 | Current |
Financial Performance of Karuna Kui Foundation.
Karuna Kui Foundation, for the financial year ended 2022, experienced significant growth in revenue, with a 343042.16% increase. The company also saw a substantial improvement in profitability, with a 303402.06% increase in profit. The company's net worth Soared by an impressive increase of 12960.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Karuna Kui Foundation?
Unlock access to Karuna Kui Foundation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Oboi Laboratories Pvt LtdSamir Shah is a mutual person
-
Cho-Spn Lifescience And Research Private LimitedSamir Shah is a mutual person
-
Ciron Drugs And Pharmaceuticals Private LimitedSamir Shah is a mutual person
-
Acco Commercial LlpFalguni Shah and Samir Shah are mutual person
-
Anantya Technologies Llp
Falguni Shah and Samir Shah are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Karuna Kui Foundation?
Unlock and access historical data on people associated with Karuna Kui Foundation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Karuna Kui Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Karuna Kui Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.